Minoru Kitago

21PUBLICATIONS
74CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Wastewater treatment processes
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Mar 28, 2026
A Pancreatic Ductal Adenocarcinoma Diagnostic System Using Serum Extracellular Vesicle Detection with Optimized Lectin Combination Using Machine Learning.

Tatsuya Kawakami, Sho Uemura, Masayuki Ono

|Oct 14, 2025
Targeting KRAS Inhibitor-Resistant Pancreatic Cancer with an MUC1-C Antibody-Drug Conjugate.

Hiroki Ozawa, Kazuki Takahashi, Tomoki Motegi

|Jul 31, 2025
ASO Visual Abstract: Perioperative 5-Fluorouracil and Portal Vein Infusion Chemotherapy followed by Adjuvant S-1 for Resected Pancreatic Cancer (TOSPAC-02): A Phase 2 Clinical Trial.

Minoru Kitago, Yutaka Endo, Yosuke Uematsu

|Jul 19, 2025
ASO Author Reflections: Perioperative 5-Fluorouracil and Portal Vein Infusion Chemotherapy Followed by Adjuvant S-1 for Resected Pancreatic Cancer (TOSPAC-02)-A Phase 2 Clinical Trial.

Minoru Kitago, Yutaka Endo, Yuko Kitagawa

|Jul 08, 2025
Splenic Metastasis of Endometrial Carcinoma Manifesting as a Hemorrhagic Splenic Cyst 17 Years After Surgery.

Minoru Kitago, Masato Kamiyama, Yuta Abe

|Jun 25, 2025
Perioperative 5-Fluorouracil and Portal Vein Infusion Chemotherapy Followed by Adjuvant S-1 for Resected Pancreatic Cancer (TOSPAC-02): A Phase 2 Clinical Trial.

Minoru Kitago, Yutaka Endo, Yosuke Uematsu

Pageof 4

Frequent Collaborators

4 joint publications

Yasushi Hasegawa

3 joint publications

Akihisa Ueno

3 joint publications

Yuta Abe

2 joint publications

Donald Kufe